Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Pediatr. 2017 Dec;191:35–41. doi: 10.1016/j.jpeds.2017.08.074

Table 3.

Neurodevelopmental outcomes at 22–26 month corrected age follow up

HOX
N= 74
LOX
N= 62
P
Value
Age at follow up assessment, months, median (interquartile range) 23 (22,24) 24 (22,25) NS
Cerebral Palsy, n (%) 8 (11%) 5(8%) NS
GMFCS score ≥2, n (%) 6 (8%) 1 (2%) NS
Vision impairment, n (%) 4 (5%) 0 NS
Permanent Deafness, n (%) 2 (3%) 2 (3%) NS
Need hearing aid, n (%) 4 (5%) 0 NS
Bayley III cognitive composite score, median (interquartile range) 85 (75,90) 85 (80,95) NS
Bayley III motor composite score, median (interquartile range) 88 (76,94) 91 (85,97) 0.01
Bayley III language composite score, median (interquartile range) 79 (71,86) 83 (74,90) NS
Neurodevelopmental impairment, n (%) 41 (55%) 25 (40%) NS
Modified neurodevelopmental impairment n (%) 32 (43%) 21 (34%) NS
Severe neurodevelopmental impairment, n (%) 13 (18%) 3 (5%) 0.04
HOX N=110* LOX N=89*
Death before follow up assessment, n (%) 21 (19%) 17 (19%) NS
NDI or Death*, n (%) 62 (54%) 42 (47%) NS
Severe NDI or Death*, n (%) 34 (31%) 20 (22%) NS

Modified NDI was calculated with Bayley III motor composite score cut off <73 instead of <85 as used in NDI definition

One infant died in HOX group after discharge from NICU. No death in LOX group after discharge from NICU

*

For primary outcome, denominator changed to total study population